Placental abruption and neonatal anemia.


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
06 2023
Historique:
received: 14 11 2022
accepted: 06 01 2023
revised: 04 01 2023
medline: 12 6 2023
pubmed: 18 1 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

Placental abruption can cause maternal blood loss and maternal anemia. It is less certain whether abruption can cause fetal blood loss and neonatal anemia. Retrospective multi-hospital 24-month analysis of women with placental abruption and their neonates. Of 55,111 births, 678 (1.2%) had confirmed abruption; 83% of these neonates (564) had one or more hemoglobins recorded in the first day. Four-hundred-seventy (83.3%) had a normal hemoglobin (≥5th% reference interval) while 94 (16.7%) had anemia, relative risk 3.26 (95% CI, 2.66-4.01) vs. >360,000 neonates from previous reference interval reports. The relative risk of severe anemia (<1st% interval) was 4.96 (3.44-7.16). When the obstetrician identified the abruption as "small" or "marginal" the risk of anemia was insignificant. Most abruptions do not cause neonatal anemia but approximately 16% do. If an abruption is not documented as small, it is important to surveille the neonate for anemia.

Identifiants

pubmed: 36650233
doi: 10.1038/s41372-023-01603-w
pii: 10.1038/s41372-023-01603-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

782-786

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011;90:140–9.
doi: 10.1111/j.1600-0412.2010.01030.x pubmed: 21241259
Ananth CV, Oyelese Y, Yeo L, Pradhan A, Vintzileos AM. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol 2005;192:191–8.
doi: 10.1016/j.ajog.2004.05.087 pubmed: 15672024
Hall DR. Abruptio placentae and disseminated intravascular coagulopathy. Semin Perinatol. 2009;33:189–95.
doi: 10.1053/j.semperi.2009.02.005 pubmed: 19464510
Downes KL, Grantz KL, Shenassa ED. Maternal, labor, delivery, and perinatal outcomes associated with placental abruption: a systematic review. Am J Perinatol. 2017;34:935–57.
doi: 10.1055/s-0037-1599149 pubmed: 28329897 pmcid: 5683164
Golditch IM, Boyce NE. Management of abruptio placentae. JAMA. 1970;212:288–93.
doi: 10.1001/jama.1970.03170150042006 pubmed: 5467229
Bruinsma MAW, de Boer MA, Prins S, Abheiden CNH. Does placental abruption cause neonatal anemia? Acta Obstet Gynecol Scand. 2022;101:917–22.
doi: 10.1111/aogs.14376 pubmed: 35582929 pmcid: 9564570
Aher S, Malwatkar K, Kadam S. Neonatal anemia. Semin Fetal Neonatal Med. 2008;13:239–47.
doi: 10.1016/j.siny.2008.02.009 pubmed: 18411074
Lokeshwar MR, Singhal T, Shah N. Anemia in the newborn. Indian J Pediatr. 2003;70:893–902.
doi: 10.1007/BF02730596 pubmed: 14703230
Stroustrup A, Trasande L. Demographics, clinical characteristics, and outcomes of neonates diagnosed with fetomaternal hemorrhage. Arch Dis Child Fetal Neonatal Ed. 2012;97:F405–10.
doi: 10.1136/archdischild-2011-300820 pubmed: 22375020
Umazume T, Yamada T, Morikawa M, Ishikawa S, Kojima T, Cho K, et al. Occult fetomaternal hemorrhage in women with pathological placenta with respect to permeability. J Obstet Gynaecol Res. 2016;42:632–9.
doi: 10.1111/jog.12959 pubmed: 26935605
Yin X, Chen Z, Yang L, Shao Q, Chen C, Feng Z. Coagulation function and placental pathology in neonates with placental abruption. Int J Clin Exp Pathol. 2018;11:604–13.
pubmed: 31938146 pmcid: 6957995
Carr NR, Henry E, Bahr TM, Ohls RK, Page JM, Ilstrup SJ, et al. Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed. Transfus (Paris). 2022;62:60–70.
doi: 10.1111/trf.16710
Maternal mortality [Internet]. [cited 2022 Nov 2]. Available from: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality .
Acun C, Karnati S, Padiyar S, Puthuraya S, Aly H, Mohamed M. Trends of neonatal hypoxic-ischemic encephalopathy prevalence and associated risk factors in the United States, 2010 to 2018. Am J Obstet Gynecol. 2022;S0002-9378:00443–4.
Parc E, Benin A, Lecarpentier E, Goffinet F, Lepercq J. Risk factors for hypoxic-ischemic encephalopathy or neonatal death in placental abruption. J Gynecol Obstet Hum Reprod. 2023;52:102498.
doi: 10.1016/j.jogoh.2022.102498 pubmed: 36336280
Bahr TM, Lawrence SM, Henry E, Ohls RK, Li S, Christensen RD. Severe anemia at birth—incidence and implications. J Pediatr. 2022;248:e2.
doi: 10.1016/j.jpeds.2022.05.045
Henry E, Christensen RD. Reference intervals in neonatal hematology. Clin Perinatol. 2015;42:483–97.
doi: 10.1016/j.clp.2015.04.005 pubmed: 26250912
Christensen, RD, Ohls, RK Anemias unique to the fetus and neonate. In: Wintrobe’s Clinical Hematology. Wolters Kluwer; 2019. p. 1039.

Auteurs

Sarah M Tweddell (SM)

Division of Neonatology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA. Sarah.Tweddell@hsc.utah.edu.

Timothy M Bahr (TM)

Division of Neonatology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT, USA.

Erick Henry (E)

Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT, USA.

Jessica M Page (JM)

Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT, USA.

Sarah J Ilstrup (SJ)

Transfusion Medicine, Intermountain Medical Center, Murray, UT, USA.

Robin K Ohls (RK)

Division of Neonatology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.

Robert D Christensen (RD)

Division of Neonatology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH